Sellas Life Sciences Group Inc - ESG Rating & Company Profile powered by AI
Alternative corporations in the scoring industry group for Sellas Life Sciences Group Inc are displayedin the table. The SDG assessment for Sellas Life Sciences Group Inc indicates the company's reporting of the UN Sustainable Development Goals. Full Sustainability analysis of Sellas Life Sciences Group Inc are reached by signing in.
Sellas Life Sciences Group Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.6; made up of an environmental score of 2.7, social score of 3.2 and governance score of 2.0.
2.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1437 | Valenta Farmatsevtika AO | 2.7 | Medium |
1437 | Wockhardt Bio AG | 2.7 | Medium |
1481 | Sellas Life Sciences Group Inc | 2.6 | Medium |
1481 | CTI Biopharma Corp | 2.6 | Medium |
1481 | Cannara Biotech Inc | 2.6 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Sellas Life Sciences Group Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc report the average age of the workforce?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc offer flexible work?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc conduct supply chain audits?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sellas Life Sciences Group Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose water use targets?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Sellas Life Sciences Group Inc have a product recall in the last two years?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sellas Life Sciences Group Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose parental leave metrics?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sellas Life Sciences Group Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose its waste policy?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc report according to TCFD requirements?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose energy use targets?
Sign up for free to unlockDoes Sellas Life Sciences Group Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sellas Life Sciences Group Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sellas Life Sciences Group Inc
These potential risks are based on the size, segment and geographies of the company.
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. The company also develops nelipepimut-S, a cancer immunotherapy that targets human epidermal growth factor receptor 2, which is in Phase 2b clinical trials for the treatment of early-stage breast cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors. The company was founded in 2012 and is headquartered in New York, New York.